2026Bilbao

ConFAC presents “Cannabis, rights and community”, a talk that champions consumption and home cultivation as fundamental rights, highlights the value of cannabis associations as spaces of care and direct democracy, and denounces legislation drawn up without social consensus. A review of current activism and an invitation to keep building the movement towards the Global Marijuana March 2026 (Marcha Mundial de la Marihuana).

In this talk we explore how the Lonjalaket model can inspire new forms of care, prevention and risk reduction in Cannabis Social Clubs (CSCs), with the backing of the Basque Government (Gobierno vasco). Lonjalaket was born as a community programme for young people and is now being reinvented and adapted to the cannabis context. We will share how this experience can bring prevention, support and care to CSCs, strengthening the role of the community.

The fight for a change in cannabis policy has gone on for far too long. While people like Aythami were creating a non-profit associative model that has served as a benchmark in other countries, we have endured decades of being singled out, stigmatised and criminalised. Now one of our own is in prison (five years for chairing a cannabis association), an injustice that keeps us standing, united and speaking with one voice: #AythamiLibertad. Fighting for everyone's rights is not a crime; it is a commitment.

Cannabis regulation in the Spanish State continues to face major challenges. This talk will address the main recent political processes – some of them still unfinished – surrounding this issue. On the one hand, it will offer a critical analysis of the role of the Study Committee on Drugs (Comisión de Estudio sobre Drogas) in the Madrid Assembly (Asamblea de Madrid), promoted by a political majority opposed to regulation, which has exploited this institutional space as a vehicle for reinforcing stigmatising discourse towards cannabis and its users. On the other, it will discuss the implementation of medicinal cannabis regulation by the Ministry of Health (Ministerio de Sanidad), a process that has now been completed but has a very limited regulatory scope.

It will also examine the persistent deadlock in the drafting of the pending regulations implementing Article 83 of the Basque Addictions Act (Ley de Adicciones del País Vasco), which recognises cannabis users' associations, as well as possible ways forward in this area.
An open dialogue on the margins, the institutional obstacles and the opportunities for progress within the State's regulatory framework.

A round table with key players in medicinal cannabis in Spain, aiming to address, from a scientific and regulatory perspective, the challenges and opportunities this plant offers. The round table will explore the potential of the autonomous communities to promote regulatory frameworks that guarantee access to unregistered medicines derived from non-patentable herbal plants, and will analyse the contradictions that cannabis generates in the pharmaceutical field.

Drugs and mental health are two of the great challenges of our time. Cannabis, the most widely used illegal substance, is often associated with a higher risk of mental disorders. This book challenges that dominant view and addresses the relationship between cannabis and mental health from a scientific and experiential perspective, concluding that, for certain people and with responsible use, cannabis may not be harmful and may even benefit psychological balance.

The cannabidiol (CBD) market is growing at a dizzying pace, but the lack of standardisation and inconsistent regulations have created an environment ripe for fraud and poor quality. Buying CBD has become a minefield. How can you really know what you are buying? Drawing on first-hand experience from more than ten years of analysing cannabis, this talk reveals the most common mistakes and scams in the buying and selling of CBD. It is a practical, straightforward guide for brands and consumers. Learn how to audit any CBD product before investing your money in it.

A reflection on the legal framework governing cannabis, CBD and psychedelic substances in Spain and internationally. The talk analyses recent legislative developments, the current situation in the courts and the outstanding challenges for the effective regulation of these compounds. It will address the situation of medicinal cannabis, industrial hemp and the marketing of CBD products, as well as the growing debate on the legality and therapeutic potential of psychedelic substances. The session will combine legal analysis with reflection on future public policy in this field of constant legal and social change.